Patricia Reyes-Uribe

Concurrent MEK2 Mutation and BRAF Amplification Confer Resistance to BRAF and MEK Inhibitors in Melanoma

Jessie Villanueva, Jeffrey R. Infante, Clemens Krepler et al. · Cell Reports · 2013 · 180 citations · Full text

Co‐targeting <scp>BET</scp> and <scp>MEK</scp> as salvage therapy for <scp>MAPK</scp> and checkpoint inhibitor‐resistant melanoma

Ileabett M. Echevarría-Vargas, Patricia Reyes-Uribe, Adam N. Guterres et al. · EMBO Molecular Medicine · 2018 · 92 citations · Full text

Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma

Patricia Reyes-Uribe, Maria Paz Adrianzen-Ruesta, Zhong Deng et al. · Oncogene · 2018 · 52 citations · Full text

Immunology, Cell Death, Tert Dependency +17

Development of Organometallic S6K1 Inhibitors

Jie Qin, Rajathees Rajaratnam, Feng Li et al. · Journal of Medicinal Chemistry · 2014 · 25 citations · Full text

Atp Binding Pocket, Molecular Biology, Molecular Pharmacology +19

Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma

Clemens Krepler, Min Xiao, Minu Samanta et al. · Oncotarget · 2016 · 23 citations · Full text